It has been demonstrated that LKB1-deficient cancers are susceptible to treatment with the biguanide phenformin, phenformin selectively inducing apoptosis in these cancer cells as opposed to cancer cell types harboring other mutations [20]. Here, STK11 is linked to cancer.